New molecular imaging techniques may lead to advances in disease treatmentJune 17, 2008Researchers present a promising cell engineering technique at the SNM 55th Annual Meeting, June 14-18 NEW ORLEANS, La.- A promising new technique has been developed that will enable more accurate non-invasive positron emission tomography (PET) imaging of new cells injected into the body, according to researchers at SNM's 55th Annual Meeting. The new technique, which involves engineering antibody fragments to act as reporter genes-or markers that signal cells of interest for PET imaging purposes-could significantly advance the study of genetically engineered cells to treat diseases. "Genetic cell engineering is the focus of intense research in almost all areas of medicine and shows great promise for treatment of common illnesses such as heart disease, diabetes, and Parkinson's disease and other neurodegenerative disorders," said Wolfgang Weber, lead researcher of the study, Cell Surface Expression of an Engineered Antibody as a PET Reporter Gene for In Vivo PET Imaging, which was performed at the Department of Molecular and Medical Pharmacology at UCLA in collaboration with the Department of Chemistry at UC Davis.
However, despite intense efforts, researchers have few solid, noninvasive methods for accurately tracking the location, function and viability of small numbers of transplanted cells. "Our research shows that using antibodies as reporter genes in PET imaging provides these capabilities and could contribute to improved treatment of a number of potentially devastating diseases," added Weber, now professor of nuclear medicine at the University of Freiburg, Germany. To improve PET imaging in this area, researchers have been studying the use of reporter gene-probe combinations. With this technique, cells are created to synthesize a protein that binds to or metabolizes radioactive reporter probes that are injected into the body and detected with PET imaging technology. However, most available reporter gene combinations are not aptly sensitive or specific and have significant limitations in terms of tracking the cells of interest to researchers. In this new research, Weber and his team explored using cell surface-bound antibody fragments as reporter genes. These engineered antibody fragments, developed by the group of Claude Meares at Davis, bind irreversibly to low-molecular-weight antigens, which act as reporter probes. Cell culture and animal studies demonstrated intense and highly specific uptake of the probes in cells expressing the antibody fragment on the cell surface. These data indicate that antibody-based reporter genes represent a promising new platform for the development of new reporter gene and probe combinations. Antibody-based reporter genes have several potential advantages over other combinations. For example, the pharmacokinetics of the reporter probe can easily be optimized, and probes can identify antibodies with much higher specificity, thus improving the accuracy of PET imaging. In addition, the number of antibodies that can be used as reporter genes is virtually unlimited compared with available viral or mammalian reporter genes. Antibody-based reporter genes have low immunogenicity and are better suited for imaging the expression of several genes. Society of Nuclear Medicine | |||||||||||||||||||||
|
Related Molecular Imaging News Articles PET scans lead to treatment changes in majority of colorectal cancer patients In the largest multi-institutional study to date examining the impact of positron emission tomography (PET) in changing disease management of individuals with suspected recurrent colorectal cancer, researchers found that treatment plans were changed for more than half of patients. Fair and adequate reimbursement is vital to developing life-saving medical treatments Reimbursement of molecular imaging and therapies-leading to the early detection and diagnosis of many life-threatening diseases-remains an urgent and critical need as consumers face ever-increasing healthcare costs. Ability to track stem cells in tumors could advance cancer treatments Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms. Molecular imaging sheds new light on progression of Alzheimer's disease In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years. New possibilities for breast cancer treatment on the horizon he first patient scans from a custom-built scanner combining positron emission tomography (PET) and computed tomography (CT) technologies indicate that these scans could significantly improve breast cancer imaging capabilities and lead to more targeted treatment options, according to researchers at SNM's 55th Annual Meeting. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease Evaluations of the first-ever prototype positron emission tomography (PET) brain scanner that uses semiconductor detectors indicate that the scanner could advance the quality and spatial resolution of PET imaging, according to researchers at SNM's 55th Annual Meeting. New study shows potential to treat or prevent viral cancers A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. Study recommends development of standards for pediatric doses in nuclear medicine Results of a recent survey of 13 pediatric hospitals in North America show a lack of universally applied standards for administering radiopharmaceutical doses to children undergoing nuclear medicine examinations, according to an article in the June issue of The Journal of Nuclear Medicine. Power of Molecular Imaging Reveals Secrets of the Heart The extraordinary action of a new cellular therapy came to light as a result of powerful PET and SPECT imaging in a recent study reported in the April issue of the Journal of Nuclear Medicine. Protein shines light on cancer response A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators. More Molecular Imaging News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||